• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室收缩功能障碍患者运动时的肺血管反应模式可预测运动能力和预后。

Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.

机构信息

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, USA.

出版信息

Circ Heart Fail. 2011 May;4(3):276-85. doi: 10.1161/CIRCHEARTFAILURE.110.959437. Epub 2011 Feb 3.

DOI:10.1161/CIRCHEARTFAILURE.110.959437
PMID:21292991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3740216/
Abstract

BACKGROUND

Elevated resting pulmonary arterial pressure (PAP) in patients with left ventricular systolic dysfunction (LVSD) purports a poor prognosis. However, PAP response patterns to exercise in LVSD and their relationship to functional capacity and outcomes have not been characterized.

METHODS AND RESULTS

Sixty consecutive patients with LVSD (age 60±12 years, left ventricular ejection fraction 0.31±0.07, mean±SD) and 19 controls underwent maximum incremental cardiopulmonary exercise testing with simultaneous hemodynamic monitoring. During low-level exercise (30 W), LVSD subjects, compared with controls, had greater augmentation in mean PAPs (15±1 versus 5±1 mm Hg), transpulmonary gradients (5±1 versus 1±1 mm Hg), and effective pulmonary artery elastance (0.05±0.02 versus -0.03±0.01 mm Hg/mL, P<0.0001 for all). A linear increment in PAP relative to work (0.28±0.12 mm Hg/W) was observed in 65% of LVSD patients, which exceeded that observed in controls (0.07±0.02 mm Hg/W, P<0.0001). Exercise capacity and survival was worse in patients with a PAP/watt slope above the median than in patients with a lower slope. In the remaining 35% of LVSD patients, exercise induced a steep initial increment in PAP (0.41±0.16 mm Hg/W) followed by a plateau. The plateau pattern, compared with a linear pattern, was associated with reduced peak Vo(2) (10.6±2.6 versus 13.1±4.0 mL · kg(-1) · min(-1), P=0.005), lower right ventricular stroke work index augmentation with exercise (5.7±3.8 versus 9.7±5.0 g/m(2), P=0.002), and increased mortality (hazard ratio 8.1, 95% CI 2.7 to 23.8, P<0.001).

CONCLUSIONS

A steep increment in PAP during exercise and failure to augment PAP throughout exercise are associated with decreased exercise capacity and survival in patients with LVSD, and may therefore represent therapeutic targets.

CLINICAL TRIAL INFORMATION

URL: http://www.clinicaltrials.gov. Unique identifier: NCT00309790.

摘要

背景

患有左心室收缩功能障碍(LVSD)的患者静息肺动脉压(PAP)升高表明预后不良。然而,LVSD 患者运动时的 PAP 反应模式及其与功能能力和结局的关系尚未确定。

方法和结果

连续 60 例 LVSD 患者(年龄 60±12 岁,左心室射血分数 0.31±0.07,均值±标准差)和 19 例对照者接受最大增量心肺运动试验,同时进行血流动力学监测。在低水平运动(30 W)时,与对照组相比,LVSD 患者的平均 PAP 增加幅度更大(15±1 对 5±1 mm Hg)、跨肺梯度更大(5±1 对 1±1 mm Hg)、有效肺动脉弹性更大(0.05±0.02 对-0.03±0.01 mm Hg/mL,均 P<0.0001)。65%的 LVSD 患者 PAP 相对于做功呈线性递增(0.28±0.12 mm Hg/W),高于对照组(0.07±0.02 mm Hg/W,P<0.0001)。PAP/瓦特斜率高于中位数的患者比斜率较低的患者运动能力和生存率更差。在剩余的 35%的 LVSD 患者中,运动引起的 PAP 初始急剧增加(0.41±0.16 mm Hg/W),随后出现平台。与线性模式相比,平台模式与峰值 Vo(2)降低(10.6±2.6 对 13.1±4.0 mL·kg(-1)·min(-1),P=0.005)、运动时右心室每搏功指数增加减少(5.7±3.8 对 9.7±5.0 g/m(2),P=0.002)和死亡率增加(风险比 8.1,95%CI 2.7 至 23.8,P<0.001)相关。

结论

LVSD 患者运动时 PAP 急剧增加且运动时 PAP 无法增加与运动能力下降和生存率降低相关,因此可能成为治疗靶点。

临床试验信息

网址:http://www.clinicaltrials.gov。唯一标识符:NCT00309790。

相似文献

1
Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.左心室收缩功能障碍患者运动时的肺血管反应模式可预测运动能力和预后。
Circ Heart Fail. 2011 May;4(3):276-85. doi: 10.1161/CIRCHEARTFAILURE.110.959437. Epub 2011 Feb 3.
2
Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular function.收缩性心力衰竭中平均 VO2 反应时间延长:右心室-肺血管功能受损的指标。
Circ Heart Fail. 2013 May;6(3):499-507. doi: 10.1161/CIRCHEARTFAILURE.112.000157. Epub 2013 Apr 9.
3
Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.肺血管扩张性可预测心力衰竭患者的肺动脉高压严重程度、运动能力及生存率。
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.003011.
4
Hemodynamic Characteristics in Significant Symptomatic and Asymptomatic Primary Mitral Valve Regurgitation at Rest and During Exercise.静息和运动时严重有症状和无症状原发性二尖瓣反流的血液动力学特征。
Circ Cardiovasc Imaging. 2018 Feb;11(2):e007171. doi: 10.1161/CIRCIMAGING.117.007171.
5
Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.左心衰竭中肺动脉高压的血流动力学表型分析
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.004082.
6
Cardiac correlates of exercise induced pulmonary hypertension in patients with chronic heart failure due to left ventricular systolic dysfunction.左心室收缩功能不全所致慢性心力衰竭患者运动诱发肺动脉高压的心脏相关因素
Echocardiography. 2008 Apr;25(4):386-93. doi: 10.1111/j.1540-8175.2007.00616.x. Epub 2008 Jan 3.
7
Pulse wave analysis of the aortic pressure waveform in severe left ventricular systolic dysfunction.严重左心室收缩功能障碍的主动脉压力波形的脉搏波分析。
Circ Heart Fail. 2010 Jan;3(1):149-56. doi: 10.1161/CIRCHEARTFAILURE.109.862383. Epub 2009 Nov 10.
8
Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.射血分数保留的心力衰竭患者右心室-肺动脉耦联受损及西地那非的作用:舒张性心力衰竭磷酸二酯酶-5抑制改善临床状态和运动能力(RELAX)试验的一项辅助分析
Circ Heart Fail. 2016 Apr;9(4):e002729. doi: 10.1161/CIRCHEARTFAILURE.115.002729.
9
Left Ventricular Dysfunction and Exercise Capacity Trajectory: Implications for Subclinical Heart Failure Staging Criteria.左心室功能障碍与运动能力轨迹:对亚临床心力衰竭分期标准的影响。
JACC Cardiovasc Imaging. 2019 May;12(5):798-806. doi: 10.1016/j.jcmg.2017.10.023. Epub 2018 Feb 14.
10
The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.心率恢复在心力衰竭或左心室收缩功能障碍患者中的重要性。
J Card Fail. 2005 Oct;11(8):624-30. doi: 10.1016/j.cardfail.2005.06.429.

引用本文的文献

1
Determinants of cardiac output in health and heart failure.健康与心力衰竭状态下的心输出量决定因素
Exp Physiol. 2025 May;110(5):637-648. doi: 10.1113/EP091505. Epub 2025 Mar 23.
2
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals With Type 2 Diabetes.年龄和性别对2型糖尿病患者全身炎症和心脏代谢功能的影响。
J Am Heart Assoc. 2025 Feb 4;14(3):e037863. doi: 10.1161/JAHA.124.037863. Epub 2025 Jan 23.
3
Combining cardiopulmonary exercise testing with echocardiography: a multiparametric approach to the cardiovascular and cardiopulmonary systems.心肺运动试验与超声心动图相结合:一种针对心血管和心肺系统的多参数方法。
Eur Heart J Imaging Methods Pract. 2023 Aug 18;1(1):qyad021. doi: 10.1093/ehjimp/qyad021. eCollection 2023 May.
4
Exploring the Noninvasive Evaluation of the Pulmonary Pressure-Flow Relationship During Exercise.探索运动期间肺压力-血流关系的无创评估。
J Am Heart Assoc. 2024 Aug 6;13(15):e036986. doi: 10.1161/JAHA.124.036986. Epub 2024 Jul 19.
5
Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction.在射血分数保留的心力衰竭中,二十烷类和与二十烷类相关的炎症介质与运动不耐受有关。
Nat Commun. 2023 Nov 20;14(1):7557. doi: 10.1038/s41467-023-43363-3.
6
The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension.二十烷类物质及其相关代谢物与肺动脉高压的关联。
Eur Respir J. 2023 Oct 19;62(4). doi: 10.1183/13993003.00561-2023. Print 2023 Oct.
7
Outcomes of right heart dysfunction in the acutely and severely unwell: protocol for a prospective, longitudinal observational study using multimodal assessment.严重急性不适患者右心功能障碍的结局:使用多模态评估的前瞻性纵向观察研究方案。
BMJ Open. 2023 Oct 17;13(10):e074571. doi: 10.1136/bmjopen-2023-074571.
8
Prognostic Role of Metabolic Exercise Testing in Heart Failure.代谢运动测试在心力衰竭中的预后作用
J Clin Med. 2023 Jun 30;12(13):4438. doi: 10.3390/jcm12134438.
9
Role of Exercise Stress Echocardiography in Pulmonary Hypertension.运动负荷超声心动图在肺动脉高压中的作用
Life (Basel). 2023 Jun 14;13(6):1385. doi: 10.3390/life13061385.
10
Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges.肥胖相关性射血分数保留型心力衰竭:诊断和治疗挑战。
Korean J Intern Med. 2023 Mar;38(2):157-166. doi: 10.3904/kjim.2022.271. Epub 2023 Feb 6.

本文引用的文献

1
PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.西地那非抑制 PDE5 可改善稳定收缩性心力衰竭患者的左心室舒张功能、心脏几何形状和临床状况:一项为期 1 年、前瞻性、随机、安慰剂对照研究的结果。
Circ Heart Fail. 2011 Jan;4(1):8-17. doi: 10.1161/CIRCHEARTFAILURE.110.944694. Epub 2010 Oct 29.
2
Right ventricular response to intensive medical therapy in advanced decompensated heart failure.右心室对晚期失代偿性心力衰竭强化药物治疗的反应。
Circ Heart Fail. 2010 May;3(3):340-6. doi: 10.1161/CIRCHEARTFAILURE.109.900134. Epub 2010 Feb 22.
3
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.2009年重点更新:美国心脏病学会基金会/美国心脏协会成人心力衰竭诊断与管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告:与国际心肺移植学会合作制定。
Circulation. 2009 Apr 14;119(14):1977-2016. doi: 10.1161/CIRCULATIONAHA.109.192064. Epub 2009 Mar 26.
4
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.健康受试者静息和运动时的肺动脉压:一项系统评价。
Eur Respir J. 2009 Oct;34(4):888-94. doi: 10.1183/09031936.00145608. Epub 2009 Mar 26.
5
Exercise-induced pulmonary arterial hypertension.运动诱发性肺动脉高压
Circulation. 2008 Nov 18;118(21):2183-9. doi: 10.1161/CIRCULATIONAHA.108.787101. Epub 2008 Nov 3.
6
Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study).运动血压与心血管疾病发病风险(来自弗雷明汉心脏研究)
Am J Cardiol. 2008 Jun 1;101(11):1614-20. doi: 10.1016/j.amjcard.2008.01.046. Epub 2008 Mar 28.
7
Effective arterial elastance as an index of pulmonary vascular load.有效动脉弹性作为肺血管负荷的指标。
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2736-42. doi: 10.1152/ajpheart.00796.2007. Epub 2008 Apr 18.
8
Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.西地那非对慢性心力衰竭患者进行四周5'-磷酸二酯酶抑制的效果:一项双盲、安慰剂对照临床试验
J Card Fail. 2008 Apr;14(3):189-97. doi: 10.1016/j.cardfail.2007.11.006.
9
Long-term use of sildenafil in the therapeutic management of heart failure.西地那非在心力衰竭治疗管理中的长期应用。
J Am Coll Cardiol. 2007 Nov 27;50(22):2136-44. doi: 10.1016/j.jacc.2007.07.078. Epub 2007 Nov 13.
10
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.西地那非可改善收缩性心力衰竭合并继发性肺动脉高压患者的运动能力和生活质量。
Circulation. 2007 Oct 2;116(14):1555-62. doi: 10.1161/CIRCULATIONAHA.107.716373. Epub 2007 Sep 4.